Hydromorphone

Generic Name
Hydromorphone
Brand Names
Dilaudid, Exalgo, Hydromorph Contin, Hydromorphone Hp Forte
Drug Type
Small Molecule
Chemical Formula
C17H19NO3
CAS Number
466-99-9
Unique Ingredient Identifier
Q812464R06
Background

Hydromorphone is a pure opioid, a semi-synthetic hydrogenated ketone derivative of morphine that has been available clinically since 1920. Structurally, hydromorphone derived from morphine in the modification of the hydroxyl group in the carbon 6 to a carbonyl and the absence of a double bond between the carbon 7 and 8. Due to these modifications, it present...

Indication

Hydromorphone is indicated for the management of moderate to severe acute pain and severe chronic pain. Due to its addictive potential and overdose risk, hydromorphone is only prescribed when other first-line treatments have failed.
...

Associated Conditions
Neuropathic Pain, Refractory Chronic Cough, Moderate to severe pain
Associated Therapies
-

Satisfactory Analgesia Minimal Emesis in Day Surgeries

First Posted Date
2014-08-22
Last Posted Date
2023-12-11
Lead Sponsor
McMaster University
Target Recruit Count
402
Registration Number
NCT02223377
Locations
🇨🇦

Hamilton Health Sciences, Hamilton, Ontario, Canada

🇨🇦

St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada

Decreasing Narcotics in Advanced Pelvic Surgery

First Posted Date
2014-04-10
Last Posted Date
2016-08-17
Lead Sponsor
Hartford Hospital
Target Recruit Count
138
Registration Number
NCT02110719
Locations
🇺🇸

Hartford Hosptial, Hartford, Connecticut, United States

Methadone and Hydromorphone For Spinal Surgery

First Posted Date
2014-04-08
Last Posted Date
2019-09-30
Lead Sponsor
NorthShore University HealthSystem
Target Recruit Count
120
Registration Number
NCT02107339
Locations
🇺🇸

NorthShore University HealthSystem, Evanston, Illinois, United States

Ketamine Patient-Controlled Analgesia for Acute Pain

First Posted Date
2014-02-14
Last Posted Date
2017-09-21
Lead Sponsor
University of Cincinnati
Target Recruit Count
20
Registration Number
NCT02062879
Locations
🇺🇸

University of Cincinnati Medical Center, Cincinnati, Ohio, United States

A Comparison Trial Between PCA and Epidural Analgesia for Pectus Excavatum Repair

Phase 4
Terminated
Conditions
Interventions
First Posted Date
2014-02-05
Last Posted Date
2020-06-11
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
62
Registration Number
NCT02056301
Locations
🇺🇸

Texas Children't Hospital, Houston, Texas, United States

Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder

First Posted Date
2014-01-23
Last Posted Date
2018-04-24
Lead Sponsor
Indivior Inc.
Target Recruit Count
39
Registration Number
NCT02044094
Locations
🇺🇸

Vince & Associates Clinical Research, Overland Park, Kansas, United States

Postoperative Pain Therapy With Hydromorphone Using TCI-PCA

Phase 4
Completed
Conditions
Interventions
First Posted Date
2014-01-14
Last Posted Date
2015-07-03
Lead Sponsor
University of Erlangen-Nürnberg Medical School
Target Recruit Count
50
Registration Number
NCT02035709
Locations
🇩🇪

Department of Anesthesiology, University Hospital Erlangen, Erlangen, Germany

Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose

First Posted Date
2013-12-12
Last Posted Date
2016-07-25
Lead Sponsor
Mayo Clinic
Target Recruit Count
84
Registration Number
NCT02009722
Locations
🇺🇸

Rochester Methodist Hospital, Mayo Clinic, Rochester, Minnesota, United States

Epidural Analgesia Versus IV Analgesia in Lumbar Spine Fusions

First Posted Date
2013-11-19
Last Posted Date
2017-02-23
Lead Sponsor
Duke University
Target Recruit Count
17
Registration Number
NCT01986946
Locations
🇺🇸

Duke University Hospital, Durham, North Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath